Design and Synthesis of Hsp90 Inhibitors with B‐Raf and PDHK1 Multi‐Target Activity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Design and Synthesis of Hsp90 Inhibitors with B‐Raf and PDHK1 Multi‐Target Activity ; day:11 ; month:10 ; year:2021 ; extent:1
ChemistryOpen ; (11.10.2021) (gesamt 1)
- Urheber
-
Pinzi, Luca
Foschi, Francesca
Christodoulou, Michael S.
Passarella, Daniele
Rastelli, Giulio
- DOI
-
10.1002/open.202100131
- URN
-
urn:nbn:de:101:1-2021101115234506089837
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pinzi, Luca
- Foschi, Francesca
- Christodoulou, Michael S.
- Passarella, Daniele
- Rastelli, Giulio
Ähnliche Objekte (12)
Combination treatment effects of BRAF (B-RAF proto-oncogene, serine/threonine kinase) inhibitors and HSP90 (heat shock protein 90) inhibitors in BRAF-mutated colorectal cancer cell lines
Targeting CDK 2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
B-Raf and the inhibitors: from bench to bedside
Functional analysis of the B-raf and raf-1 proto oncogenes in B lymphocytes
Phospho-proteomic analysis of B-Raf complexes
Mutationsscreening von A-Raf und B-Raf in humanen Glioblastom-Tumorproben
The Role of Raf-1 and B-Raf in B cell activation, differentiation, and tumorigenesis in mice
B-Raf regulation by the dimer interface and activation loop phosphorylation
The mechanism of activation of MEK1 by B-Raf and KSR1
Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors
B-Raf specific antibody responses in melanoma patients
The role of the Β-Raf activation loop in development and cancer
Combination treatment effects of BRAF (B-RAF proto-oncogene, serine/threonine kinase) inhibitors and HSP90 (heat shock protein 90) inhibitors in BRAF-mutated colorectal cancer cell lines
Targeting CDK 2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
B-Raf and the inhibitors: from bench to bedside
Functional analysis of the B-raf and raf-1 proto oncogenes in B lymphocytes
Phospho-proteomic analysis of B-Raf complexes
Mutationsscreening von A-Raf und B-Raf in humanen Glioblastom-Tumorproben
The Role of Raf-1 and B-Raf in B cell activation, differentiation, and tumorigenesis in mice
B-Raf regulation by the dimer interface and activation loop phosphorylation
The mechanism of activation of MEK1 by B-Raf and KSR1
Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors
B-Raf specific antibody responses in melanoma patients
The role of the Β-Raf activation loop in development and cancer
Combination treatment effects of BRAF (B-RAF proto-oncogene, serine/threonine kinase) inhibitors and HSP90 (heat shock protein 90) inhibitors in BRAF-mutated colorectal cancer cell lines
Targeting CDK 2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
B-Raf and the inhibitors: from bench to bedside
Functional analysis of the B-raf and raf-1 proto oncogenes in B lymphocytes
Phospho-proteomic analysis of B-Raf complexes
Mutationsscreening von A-Raf und B-Raf in humanen Glioblastom-Tumorproben
The Role of Raf-1 and B-Raf in B cell activation, differentiation, and tumorigenesis in mice
B-Raf regulation by the dimer interface and activation loop phosphorylation
The mechanism of activation of MEK1 by B-Raf and KSR1
Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors
B-Raf specific antibody responses in melanoma patients